The apoptotic-cell receptor CR3, but not ανβ5, is a regulator of human dendritic-cell immunostimulatory function

被引:96
作者
Skoberne, Mojca
Somersan, Selin
Almodovar, Wanda
Truong, Tuan
Petrova, Kseniya
Henson, Peter M.
Bhardwaj, Nina
机构
[1] NYU, Sch Med, New York, NY 10016 USA
[2] Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO USA
关键词
D O I
10.1182/blood-2005-12-4812
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dendritic cells (DCs) that capture apoptotic cells (ACs) in the steady state mediate peripheral tolerance to self-antigens. ACs are recognized by an array of receptors on DCs, the redundancy of which is not completely defined. We made use of an AC surrogate system to address the individual roles of the alpha v beta 5 and complement receptors (CRs) in the phagocytosis and induction of immunity. CR3 and CR4, while substantially less efficient than alpha v beta 5 in internalizing ACs, initiate signals that render DCs tolerogenic. Responding T cells show impaired proliferation and IFN gamma production and subsequently die by apoptosis. While tolerogenic DCs are not induced via alpha v beta 5, coligation of CR3 and alpha v beta 5 maintains the DC's tolerogenic profile. This immunomodulatory role, however, is countered by a significant inflammatory stimulus such as bacterial infection. Overall, our data suggest that under steady-state conditions, signaling via CRs predominates to render DCs tolerogenic.
引用
收藏
页码:947 / 955
页数:9
相关论文
共 59 条
  • [1] CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells
    Adler, AJ
    Marsh, DW
    Yochum, GS
    Guzzo, JL
    Nigam, A
    Nelson, WG
    Pardoll, DM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) : 1555 - 1564
  • [2] αvβ5 integrin recruits the Crkll-Dock180-Rac1 complex for phagocytosis of apoptotic cells
    Albert, ML
    Kim, JI
    Birge, RB
    [J]. NATURE CELL BIOLOGY, 2000, 2 (12) : 899 - 905
  • [3] Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
    Albert, ML
    Pearce, SFA
    Francisco, LM
    Sauter, B
    Roy, P
    Silverstein, RL
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) : 1359 - 1368
  • [4] CD36 is differentially expressed by CD8+ splenic dendritic cells but is not required for cross-presentation in vivo
    Belz, GT
    Vremec, D
    Febbraio, M
    Corcoran, L
    Shortman, K
    Carbone, FR
    Heath, WR
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (12) : 6066 - 6070
  • [5] Novel IL-12 family members shed light on the orchestration of Th1 responses
    Brombacher, F
    Kastelein, RA
    Alber, G
    [J]. TRENDS IN IMMUNOLOGY, 2003, 24 (04) : 207 - 212
  • [6] Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases
    Caron, E
    Hall, A
    [J]. SCIENCE, 1998, 282 (5394) : 1717 - 1721
  • [7] The expanding B7 superfamily: Increasing complexity in costimulatory signals regulating T cell function
    Coyle, AJ
    Gutierrez-Ramos, JC
    [J]. NATURE IMMUNOLOGY, 2001, 2 (03) : 203 - 209
  • [8] Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation
    Delneste, Y
    Magistrelli, G
    Gauchat, JF
    Haeuw, JF
    Aubry, JP
    Nakamura, K
    Kawakami-Honda, N
    Goetsch, L
    Sawamura, T
    Bonnefoy, JY
    Jeannin, P
    [J]. IMMUNITY, 2002, 17 (03) : 353 - 362
  • [9] Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
    Dhodapkar, MV
    Steinman, RM
    Krasovsky, J
    Munz, C
    Bhardwaj, N
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 233 - 238
  • [10] Fadok VA, 1998, J IMMUNOL, V161, P6250